» Articles » PMID: 35784974

The Nexus Between Diabetes and Depression: A Narrative Review

Overview
Journal Cureus
Date 2022 Jul 5
PMID 35784974
Authors
Affiliations
Soon will be listed here.
Abstract

Comorbid diabetes and depression are a significant public health burden as the consequences of both diseases are worsened by each other. In this study, we have compiled and analyzed findings from various studies to demonstrate that diabetes has a strong association with depression. Both have a significant impact on the quality of life, although the exact mechanisms through which these two chronic diseases affect each other remain unknown. This article discussed the shared etiological factors of comorbidity between diabetes and depression, including physiological (e.g., deregulation of the hypothalamic-pituitary-adrenal (HPA) axis, sympathetic nervous system (SNS) overactivity, microvascular dysfunction, arterial stiffening, inflammation, and cytokines), behavioral (e.g., diet and lifestyle modifications), and environmental (e.g., childhood adversity, poverty, and neighborhood environment). Included data from a range of settings have suggested that the prognosis of both diabetes and depression, in terms of complications, treatment efficacy, morbidity, and mortality, is worse for either disease when they occur concurrently than individually. The implication for the physical, mental, and social well-being of depression in diabetes causes poor self-care and adherence to medical treatment. This article also highlights the importance of regular screening and prompts the treatment of comorbid diabetes and depression with pharmacotherapy, face-to-face psychotherapy, and non-face-to-face models of alternative psychological interventions, including information and communication technologies (ICTs), computer-based diabetes self-management interventions, and digital mental health intervention, to improve the outcomes of both diseases.

Citing Articles

Blinded by the Mind: Exploring the Hidden Psychiatric Burden in Glaucoma Patients.

Jesus J, Ambrosio J, Meira D, Rodriguez-Una I, Beirao J Biomedicines. 2025; 13(1).

PMID: 39857700 PMC: 11763043. DOI: 10.3390/biomedicines13010116.


Bidirectional relationship between diabetes mellitus and depression: Mechanisms and epidemiology.

Liu Y, Huang S, Liu D, Zeng X, Pan X, Peng J World J Psychiatry. 2024; 14(10):1429-1436.

PMID: 39474387 PMC: 11514559. DOI: 10.5498/wjp.v14.i10.1429.


Targeting self-care adherence for glycaemic control in multimorbid type 2 diabetes mellitus with depression using bupropion: a protocol for cross-over randomised controlled trial.

Shamim M, Shukla R, Swami M, Srivastav S, Pradhan A, Yadav S BMJ Open. 2024; 14(6):e077975.

PMID: 38834315 PMC: 11163640. DOI: 10.1136/bmjopen-2023-077975.


Moderating Effect of Grip Strength in the Association between Diabetes Mellitus and Depressive Symptomatology.

Veiga D, Peralta M, Gouveia E, Carvalho L, Encantado J, Teixeira P Sports (Basel). 2024; 12(1).

PMID: 38275982 PMC: 10819407. DOI: 10.3390/sports12010003.


Evaluating Clinical Outcomes in Patients Being Treated Exclusively via Telepsychiatry: Retrospective Data Analysis.

Person C, OConnor N, Koehler L, Venkatachalam K, Gaveras G JMIR Form Res. 2023; 7:e53293.

PMID: 37991899 PMC: 10746963. DOI: 10.2196/53293.


References
1.
Varela-Moreno E, Carreira Soler M, Guzman-Parra J, Jodar-Sanchez F, Mayoral-Cleries F, Anarte-Ortiz M . Effectiveness of eHealth-Based Psychological Interventions for Depression Treatment in Patients With Type 1 or Type 2 Diabetes Mellitus: A Systematic Review. Front Psychol. 2022; 12:746217. PMC: 8842796. DOI: 10.3389/fpsyg.2021.746217. View

2.
Lustman P, Freedland K, Griffith L, Clouse R . Predicting response to cognitive behavior therapy of depression in type 2 diabetes. Gen Hosp Psychiatry. 1998; 20(5):302-6. DOI: 10.1016/s0163-8343(98)00039-5. View

3.
Pan A, Sun Q, Okereke O, Rexrode K, Rubin R, Lucas M . Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia. 2011; 55(1):63-72. PMC: 3229672. DOI: 10.1007/s00125-011-2268-4. View

4.
Roy T, Lloyd C, Pouwer F, Holt R, Sartorius N . Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med. 2011; 29(2):164-75. DOI: 10.1111/j.1464-5491.2011.03401.x. View

5.
Chen G, Xu R, Wang Y, Wang P, Zhao G, Xu X . Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Endocrinol Metab. 2012; 303(5):E563-75. PMC: 3774327. DOI: 10.1152/ajpendo.00591.2011. View